NCT05161702
- Conditions
- Reduction of Cell Proliferation, Resolution of Inflammation
- Locations
-
- SCF Pharma Rimouski, Quebec, Canada
Clinical trial condition
Explore clinical trials studying Resolution of Inflammation. Study availability and eligibility vary by location and protocol.
NCT05161702